Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant Recruiting Phase 2 Trials for Vinblastine (DB00570)

IndicationStatusPhase
DBCOND0118963 (Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03912818Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder CancerTreatment